ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 415 out of 1499

$392K Total Retail Price of All Prescriptions

Rank: 506 out of 1499

367 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 367 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 426 356 1 3
LEVOTHYROXINE SODIUM 336 298 2 2
AMLODIPINE BESYLATE 327 312 3 6
LISINOPRIL 324 297 4 1
HYDROCODONE-ACETAMINOPHEN 290 204 S3 5 4
OMEPRAZOLE 265 248 6 5
METFORMIN HCL 201 173 7 8
WARFARIN SODIUM 181 164 8 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 149 9 25
FUROSEMIDE 170 163 10 7
SERTRALINE HCL 165 130 11 24
CARVEDILOL 143 124 12 22
TAMSULOSIN HCL 141 119 13 29
ZOLPIDEM TARTRATE 138 84 14 23
TRAMADOL HCL 136 126 15 16
CITALOPRAM HBR 124 124 16 14
ALENDRONATE SODIUM 117 117 17 33
HYDROCHLOROTHIAZIDE 115 106 18 9
METOPROLOL TARTRATE 109 109 19 10
TRAZODONE HCL 105 98 20 32
METOPROLOL SUCCINATE 102 102 21 20
LOVASTATIN 96 90 22 19
GABAPENTIN 93 69 23 13
MELOXICAM 91 87 24 27
PREDNISONE 90 79 25 42
POTASSIUM CHLORIDE 89 85 26 11
VERAPAMIL ER 84 79 27 117
PAROXETINE HCL 84 77 27 59
ATORVASTATIN CALCIUM 75 74 29 17
RANITIDINE HCL 70 60 30 15
TRIAMTERENE-HCTZ 70 67 30 62
DONEPEZIL HCL 70 62 30 35
ATENOLOL 62 62 33 21
NEXIUM 60 51 34 28
PANTOPRAZOLE SODIUM 58 55 35 48
MIRTAZAPINE 58 56 35 50
LOSARTAN POTASSIUM 53 53 37 26
CRESTOR 52 44 38 34
POLYETHYLENE GLYCOL 3350 52 52 38 52
GEMFIBROZIL 52 37 38 88
DILTIAZEM 24HR CD 51 49 41 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.